Proteome Sciences plc (LON:PRM – Get Free Report) shares traded up 2.6% during trading on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.15 ($0.04). 555,891 shares traded hands during trading, an increase of 247% from the average session volume of 160,411 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Down 2.3 %
The company has a market capitalization of £8.86 million, a PE ratio of -300.00 and a beta of 0.07. The firm has a 50-day moving average of GBX 2.71 and a two-hundred day moving average of GBX 3.16.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- The Role Economic Reports Play in a Successful Investment Strategy
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What Does a Stock Split Mean?
- CarMax Gets in Gear: Is Now the Time to Buy?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
